BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15999733)

  • 1. [Urinary N-acetyl-beta-D-glucosaminidase (NAG) in patients with diabetes mellitus].
    Suzuki T; Igari Y; Oba K
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():352-7. PubMed ID: 15999733
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urinary N-acetyl-beta-D-glucosaminidase (NAG) in patients with diabetes mellitus].
    Suzuki T; Igari Y; Oba K
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():586-91. PubMed ID: 12355814
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urinary N-acetyl-beta-D-glucosaminidase (NAG) in patients with diabetes mellitus].
    Oba K; Nakano H; Hirai M; Sato S
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():400-6. PubMed ID: 9513451
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
    Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
    Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
    Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
    Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of beta-thromboglobulin and N-acetyl-beta-D-glucosaminidase in type 1 diabetes: potential indicators of early nephropathy?
    Patrick AW; Oliver MD; Howie AF; Dawes J; Macintyre CC; Frier BM
    Diabete Metab; 1990; 16(5):441-7. PubMed ID: 2150050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Excretion of beta-N-acetylglucosaminidase in urine in type I and type II diabetic patients with and without nephropathy].
    Werle E; Bostedt A; Fiehn W; Hasslacher C
    Wien Klin Wochenschr Suppl; 1991; 189():59-62. PubMed ID: 1962487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between asymptomatic leukocyturia and urinary N-acetyl-β-d-glucosaminidase in women.
    Sekimizu K; Suzuki T; Igari Y; Okazaki M; Hashimoto M; Suzuki K; Ouchi M; Watanabe K; Nakano H; Oba K
    Ren Fail; 2012; 34(9):1079-83. PubMed ID: 22906200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [N-acetyl-beta-D-glucosaminidase].
    Sugita O
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():307-12. PubMed ID: 9513435
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].
    Minakami H
    Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urinary proteins in patients with diabetes mellitus].
    Hofmann W; Guder WG
    Klin Wochenschr; 1989; 67 Suppl 17():37-9. PubMed ID: 2472508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [N-acetyl-beta-D-glucosaminidase].
    Furuhata N; Shiba K; Nara N
    Nihon Rinsho; 1995 May; 53(5):1267-76. PubMed ID: 7602790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubular markers in children with insulin-dependent diabetes mellitus.
    Calişkan S; Fiçicioğlu C; Hacibekiroğlu M; Mikla S; Kasapçopur O; Sever L; Aydin A; Arisoy N
    Turk J Pediatr; 1997; 39(2):213-8. PubMed ID: 9223919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urinary enzymes as markers of functional state of kidneys with diabetic lesions].
    Myhal' LIa; Korol' LV; Nikulina HH; Dudar IO; Zheltovs'ka NV
    Fiziol Zh (1994); 2006; 52(1):89-93. PubMed ID: 16553303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the activities of urinary N-acetyl-beta, D-glucosaminidase in diabetic patients].
    Arao M; Matsumiya K; Hasegawa K; Horiuchi N; Sasaki A
    Rinsho Byori; 1988 Feb; 36(2):177-81. PubMed ID: 3379789
    [No Abstract]   [Full Text] [Related]  

  • 16. Tubular dysfunction in the early stage of diabetic nephropathy.
    Tanaka A; Shima K; Fukuda M; Tahara Y; Yamamoto Y; Kumahara Y
    Med J Osaka Univ; 1989 Mar; 38(1-4):57-63. PubMed ID: 2485397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of urinary N-acetyl-beta-D-glucosaminidase for predicting early stage diabetic nephropathy.
    Kato H; Takashima T; Kishikawa H; Emura S; Ohmori K
    Int J Clin Pract; 1997; 51(8):489-90. PubMed ID: 9536599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary N-acetyl-beta-glucosaminidase excretion in non-insulin-dependent diabetes mellitus: relation with diabetic nephropathy.
    Pérez-Blanco FJ; Sabatel-Hernández G; Cantero-Hinojosa J; Rodriguez-Cuartero A
    Clin Nephrol; 1998 Feb; 49(2):132-4. PubMed ID: 9524787
    [No Abstract]   [Full Text] [Related]  

  • 19. Urinary N-acetyl-beta-D-glucosaminidase activity in type I diabetes mellitus.
    Mungan N; Yuksel B; Bakman M; Topaloglu AK; Ozer G
    Indian Pediatr; 2003 May; 40(5):410-4. PubMed ID: 12768043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
    Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.